美国 · 股市与财经 · Institutional Investor
Biopharma Continues to Buoy the IPO Market
It’s been a rough year for IPOs. So far, just 110 companies have gone public, a 29.9 percent decline from the same period last year, according to Renaissance Capital. One of the…
在 Institutional Investor 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.institutionalinvestor.com)
